WASHINGTON (AP) — The Food and Drug Administration has paved the way for children ages 5 to 11 to get Pfizer’s COVID-19 vaccine.
The agency authorized the kid-size doses on Friday.
But there’s one more regulatory hurdle.
Next week, advisers to the Centers for Disease Control and Prevention will discuss which youngsters should get vaccinated.
In the meantime, Pfizer plans to begin shipping millions of vials of the pediatric vaccine to doctor’s offices, pharmacies and other vaccination sites.
The kid-size doses are just a third of the amount given to teens and adults.